Clinical trial
Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal…
NCT00295607 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00295607 |
|---|---|
| Title | Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients |
| Official title | Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in HCV Positive in Liver Transplantation |
| Acronym | CHASE |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C, Liver Transplantation |
| Intervention type | Drug |
| Interventions | Tacrolimus, steroids, monoclonal anti-IL2R antibody |
| Enrollment | 138 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Feb 24, 2006 |
| Last update posted | Apr 11, 2013 |
| Countries | Czechia, France, Germany, Italy, Poland, Spain, Sweden, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: